2-Deoxyglucose: An anticancer and antiviral therapeutic, but not any more a low glucose mimetic
- 18 August 2005
- journal article
- review article
- Published by Elsevier
- Vol. 78 (12) , 1392-1399
- https://doi.org/10.1016/j.lfs.2005.07.001
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Glucose, but not glutamine, protects against spontaneous and anti-Fas antibody-induced apoptosis in human neutrophilsClinical Science, 2002
- Differential Regulation of Hepatitis B Virus Gene Expression by the Sp1 Transcription FactorJournal of Virology, 2001
- Sp1 Phosphorylation by Erk 2 Stimulates DNA BindingBiochemical and Biophysical Research Communications, 1999
- Caloric Restriction and AgingScientific American, 1996
- Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal RepeatJournal of Biological Chemistry, 1995
- The Glucose-Regulated Proteins (GRP78 and GRP94): Functions, Gene Regulation, and ApplicationsCritical Reviews™ in Eukaryotic Gene Expression, 1994
- Multifactorial control of insulin receptor gene expression in human cell linesBiochemical and Biophysical Research Communications, 1990
- Regulation of SV40 early gene expressionBiochemistry and Cell Biology, 1988
- Inhibition of the Multiplication of Enveloped RNA-viruses by Glucosamine and 2-Deoxy-D-GlucoseJournal of General Virology, 1972
- Inhibition of Influenza Virus Multiplication with a Glucose Antimetabolite (2-deoxy-D-glucose)Nature, 1959